Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JUAN M GONZALEZ

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1598767253
CMS profile
163340
Location
HOUSTON, TX

General Payments · PY2018–2024

$4,020.35

  • Reported across 192 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$452.45

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $452.45 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,129.33 57
PY2019 $1,076.29 54
PY2020 $323.45 16
PY2021 $192.48 10
PY2022 $462.45 20
PY2023 $383.90 19
PY2024 $452.45 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $17.32 10/21/2024 Food and Beverage Undisputed 01/23/2026 1093914794 CMS
Amgen Inc. $22.43 11/06/2024 Food and Beverage Undisputed 01/23/2026 1111586584 CMS
AstraZeneca Pharmaceuticals LP $23.39 11/18/2024 Food and Beverage Undisputed 01/23/2026 1105729245 CMS
Bayer Healthcare Pharmaceuticals Inc. $72.45 04/26/2024 Food and Beverage Undisputed 01/23/2026 1086248372 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.33 01/22/2024 Food and Beverage Undisputed 01/23/2026 1118075147 CMS
CALLIDITAS THERAPEUTICS US INC. $21.85 11/04/2024 Food and Beverage Undisputed 01/23/2026 1141526260 CMS
Daiichi Sankyo Inc. $28.58 11/26/2024 Food and Beverage Undisputed 01/23/2026 1089427075 CMS
Fresenius USA Marketing, Inc. $24.94 02/28/2024 Food and Beverage Undisputed 01/23/2026 1154210132 CMS
Novartis Pharmaceuticals Corporation $33.57 02/06/2024 Food and Beverage Undisputed 01/23/2026 1086945359 CMS
Novartis Pharmaceuticals Corporation $34.35 04/30/2024 Food and Beverage Undisputed 01/23/2026 1086945361 CMS
Novartis Pharmaceuticals Corporation $33.60 08/20/2024 Food and Beverage Undisputed 01/23/2026 1086945365 CMS
Novo Nordisk Inc $19.28 02/06/2024 Food and Beverage Undisputed 01/23/2026 1096645942 CMS
Novo Nordisk Inc $22.66 03/27/2024 Food and Beverage Undisputed 01/23/2026 1096814209 CMS
Novo Nordisk Inc $18.11 04/30/2024 Food and Beverage Undisputed 01/23/2026 1097668531 CMS
Otsuka America Pharmaceutical, Inc. $24.30 11/13/2024 Food and Beverage Undisputed 01/23/2026 1118899572 CMS
Veloxis Pharmaceuticals, Inc. $39.29 09/18/2024 Food and Beverage Undisputed 01/23/2026 1147093278 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.